We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Lifepoint Health, Inc. (delisted) | NASDAQ:LPNT | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 64.99 | 65.00 | 199,999.99 | 0 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): February 14, 2017
LIFEPOINT HEALTH, INC.
(Exact Name of Registrant as Specified in Charter)
Delaware |
|
000-51251 |
|
20-1538254 |
(State or Other Jurisdiction
|
|
(Commission File Number) |
|
(IRS Employer
|
330 Seven Springs Way
|
|
37027 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
(615) 920-7000
(Registrants telephone number, including area code)
Not Applicable
(Former name or address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 14, 2017, Paul D. Gilbert resigned as Executive Vice President and Chief Legal Officer of LifePoint Health, Inc. (the Company), effective as of such date, but Mr. Gilbert will remain a non-executive employee of the Company until March 31, 2017, to assist with certain transition matters.
In connection with his resignation, Mr. Gilbert entered into a voluntary separation and general release agreement with the Company. The agreement provides for (i) a release of all claims by Mr. Gilbert in favor of the Company, subject to customary exceptions, (ii) a 24 month non-solicitation covenant by Mr. Gilbert and (iii) payment by the Company to Mr. Gilbert of his base salary for 12 months and a payment equal to six months of COBRA premiums. In addition, Mr. Gilbert will be eligible to receive an annual bonus based on 2017 performance, up to a maximum of $250,000.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
LIFEPOINT HEALTH, INC . |
|
|
|
|
|
By: |
/s/ Michael S. Coggin |
|
|
Name: Michael S. Coggin |
|
|
Title: Executive Vice President and Chief Financial Officer |
|
|
|
Dated: February 16, 2017 |
|
|
1 Year LifePoint Health, Inc. Chart |
1 Month LifePoint Health, Inc. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions